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A fat-tissue sensor couples growth to oxygen
availability by remotely controlling insulin secretion
Michael J. Texada 1, Anne F. Jørgensen 1,2, Christian F. Christensen1, Takashi Koyama 1, Alina Malita1,
Daniel K. Smith1, Dylan F. M. Marple1, E. Thomas Danielsen 1, Sine K. Petersen1, Jakob L. Hansen2,
Kenneth A. Halberg 1 & Kim F. Rewitz 1
Organisms adapt their metabolism and growth to the availability of nutrients and oxygen,
which are essential for development, yet the mechanisms by which this adaptation occurs are
not fully understood. Here we describe an RNAi-based body-size screen in Drosophila to
identify such mechanisms. Among the strongest hits is the ﬁbroblast growth factor receptor
homolog breathless necessary for proper development of the tracheal airway system.
Breathless deﬁciency results in tissue hypoxia, sensed primarily in this context by the fat
tissue through HIF-1a prolyl hydroxylase (Hph). The fat relays its hypoxic status through
release of one or more HIF-1a-dependent humoral factors that inhibit insulin secretion from
the brain, thereby restricting systemic growth. Independently of HIF-1a, Hph is also required
for nutrient-dependent Target-of-rapamycin (Tor) activation. Our ﬁndings show that the fat
tissue acts as the primary sensor of nutrient and oxygen levels, directing adaptation of
organismal metabolism and growth to environmental conditions.
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Multicellular organisms must adapt their metabolism andgrowth to limitations imposed by their environment.Genetic and physiological pathways such as growth
factor systems regulate these adaptations, and these in turn are
inﬂuenced by internal and external cues. Among these are
nutrient availability, which promotes growth through the insulin/
insulin-like growth factor (I/IGF) pathways1,2, and oxygen sufﬁ-
ciency, which is also essential for the growth and development
of animals3,4. The signaling pathways that regulate these funda-
mental aspects of development are evolutionarily ancient and
well conserved.
I/IGF is the major systemic nutrient-dependent growth reg-
ulator and acts through conserved pathways to promote cellular
growth5,6. Many connections between nutritional cues and sys-
temic insulinergic regulation have been elucidated in the fruit
ﬂy Drosophila melanogaster. Several Drosophila insulin-like pep-
tides (DILPs or simply insulin below), primarily DILP2, -3, and
-5, are released into circulation from the insulin-producing cells
(IPCs) of the brain7. Despite their different location, these cells
are functionally homologous with mammalian pancreatic β-cells8.
The DILPs signal through a single receptor (InR) to regulate
both metabolism and growth. DILP expression and release are
regulated in part by nutritional information relayed through the
fat body, an organ analogous to vertebrate adipose and liver tis-
sues with nutrient storage, metabolic, and endocrine functions.
This tissue secretes insulinotropic (Unpaired-2, functionally
analogous to the mammalian adipokine Leptin9; the peptide
hormones CCHamide-2 (CCHa-2)10, FIT11, and Growth-
Blocking Peptides (GPBs) 1 and 212,13; the Activin ligand Daw-
dle (Daw)14,15; and the protein Stunted (Sun)16) and insulino-
static (the tumor necrosis factor-α homolog Eiger (Egr)17) factors,
many of these in response to nutrient-dependent activity of
the Target-of-rapamycin (Tor) pathway. Thus, this tissue is a
central nexus for nutritional signals that mediate adaptation to
nutritional deprivation.
Organisms require oxygen in addition to nutrients for growth
and development and have therefore developed oxygen-sensing
and adaptation mechanisms. In Drosophila and many other
organisms, hypoxia (low oxygen) restricts systemic growth and
reduces body size3,18–22, and in humans the limited oxygen
associated with high-altitude living has been linked to slow
growth and developmental delay23,24. These effects occur at
oxygen concentrations above those that compromise basic
metabolism25,26, indicating that they do not reﬂect limited
aerobic respiration but rather an active adaptation under genetic
control. The conserved transcription factor hypoxia-inducible
factor 1 alpha (HIF-1a) is the key regulator required for these
adaptive responses. At a rate proportional to oxygen levels, it is
marked for degradation by HIF-1a prolyl hydroxylase (Hph)27.
Thus, under hypoxic conditions, HIF-1a is able to perdure and
(with its constitutively present beta subunit) induce target-gene
expression. Although it is well established that nutrients mainly
affect growth through insulin, the mechanism by which animals
adaptively limit growth under oxygen limitation remains to be
determined.
We describe here an RNA interference (RNAi)-based screen
for body-size defects, covering genes encoding potential secreted
factors and their receptors, in which we identify breathless (btl)28,
encoding a ﬁbroblast growth factor receptor (FGFR) homolog, as
one of the strongest hits. This receptor is expressed by cells of the
tracheae, the gas-delivery tubules of the insect respiratory system.
Its FGF-like ligand Branchless (Bnl) is produced by target tissues
in a stereotyped pattern and in response to tissue hypoxia during
development29,30 to guide the tracheal terminal branches toward
target tissues. When this system is perturbed, internal tissues
experience hypoxia. We ﬁnd that inducing tissue hypoxia by
manipulating Btl-mediated tracheal outgrowth or external O2
levels, or genetically inducing ectopic hypoxia responses via Hph
or HIF-1a perturbation, alters the expression of Dilp2, -3, and -5
in the IPCs and blocks DILP release, leading to reduced systemic
insulin signaling. We further report that the primary sensor of
internal oxygen availability is the fat body. Both hypoxia and
amino acid (AA) insufﬁciency block Hph activity in this tissue,
and this effect propagates through two divergent pathways
downstream of Hph: HIF-1a-independent inhibition of the
Tor pathway alters adipose-tissue physiology, whereas a Tor-
independent, HIF-1a-dependent pathway leads to the release of
one or more humoral factor(s) that strongly inhibit DILP release
and thereby adapt organismal growth to oxygen availability.
Thus, Hph/HIF-1a and Hph/Tor pathways in the fat body
function as central integrators of both oxygen and AA levels to
adapt growth and metabolism to environmental conditions.
Understanding the changes brought about by hypoxia in this
model system may allow greater understanding of human disease
associated with tissue hypoxia such as obesity and diabetes.
Results
In-vivo RNAi screen for signals affecting body size. We
undertook a genetic RNAi31,32 screen targeting 1845 genes
encoding the Drosophila secretome and receptome (Fig. 1a,
Supplementary Data 1). Ubiquitous knockdown using the
daughterless-GAL4 driver (da>) identiﬁed 89 genes whose
manipulation resulted in signiﬁcant size phenotypes (Fig. 1b, c).
Among these were several genes associated with body or tissue
growth including Insulin receptor (InR)33, Anaplastic lymphoma
kinase (Alk)34 and jelly belly (jeb)35, Epidermal growth-factor
receptor (Egfr)36, and the prothoracicotropic hormone
(PTTH) receptor torso37, thus validating our approach. Genes
important for ecdysone signaling (knirps, Eip75B, Npc2g, and
torso37–40) were among the hits that increased pupal body size,
consistent with the growth-limiting effects of ecdysone, whereas
knockdown of the growth-promoting InR produced a strong
decrease in size. We identiﬁed FGF-pathway signaling (Supple-
mentary Fig. 1) among the strongest hits associated with reduced
growth. The main hit, the FGFR ortholog btl, and its FGF-like
ligand Bnl, are critical for proper tracheation of tissues to allow
for gas exchange and oxygen delivery28.
FGF signaling affects systemic growth via tracheal effects.
Ubiquitous btl (da > btl-RNAi) and bnl (da > bnl-RNAi) knockdown
strongly reduced growth and pupal size (Fig. 2a, b). Knockdown of
the upstream transcription factor trachealess (trh)41, also required
for tracheal formation, reduced body size to a lesser degree, perhaps
because of low RNAi efﬁciency or Trh-independent signaling later
in development42. btl is mainly expressed in the tracheal system but
it is also active in other cells43. To identify the tissue causing the
size phenotype, we assayed effects of btl RNAi in the tracheae (btl >
btl-RNAi), neurons (elav>), musculature (Mef2>), fat body (ppl>),
and glia (repo>). Only tracheal knockdown of btl led to reduced
body size (Fig. 2c). RNAi speciﬁcity was conﬁrmed with two
additional independent btl-RNAi lines (Supplementary Fig. 2a).
Knockdown of btl in the tracheae delayed pupariation, thus
prolonging the larval growth period, suggesting that small size
resulted from reduced growth rate (Supplementary Fig. 2b). We
therefore measured the growth rate during the third larval instar
(L3) and found indeed that tracheal btl RNAi systemically slowed
body growth (Fig. 2d). Thus, btl is required in the tracheal system
for normal systemic growth, possibly via effects on oxygen delivery.
The btl-RNAi size phenotype is mediated by insulin. Among the
primary regulators of systemic growth in Drosophila are the
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DILPs7. To assess whether the body-size phenotype of btl
knockdown is mediated by altered insulin signaling, we ﬁrst
examined the effects of directly reducing insulin signaling. As
expected, globally reducing insulin signaling (da > InR-RNAi) or
blocking Tor-dependent fat-body nutrient signaling through
expression of Tsc1 and Tsc2 (ppl > Tsc1/2) strongly reduced pupal
size and prolonged larval development (Fig. 3a, Supplementary
Fig. 3a), phenocopying tracheal btl loss. To determine whether
btl > btl-RNAi might cause insulin expression changes, we quan-
tiﬁed Dilp2, -3, and -5 transcripts in feeding L3s, ~ 24 h before
pupariation. Indeed, very strong reduction (>90%) of Dilp3
expression was observed in RNAi animals, accompanied by a
smaller decrease in Dilp5 transcripts (Fig. 3b).
Insulin activity is also regulated at the level of DILP release44,
and we therefore investigated whether tracheal btl loss might
induce IPC retention of DILP2, -3, and -5. Knockdown induced
an accumulation of these peptides in the IPCs (Fig. 3c), despite
the reduced expression of Dilp3 and Dilp5. This suggests that btl
> btl-RNAi induces a strong decrease in DILP secretion, which
should reduce peripheral activity downstream of InR. Insulin
signaling leads to the phosphorylation of the kinase Akt and to
suppression of InR expression as part of a sensitivity-regulating
feedback circuit45. We indeed observed InR upregulation and
phosphorylated Akt (pAkt) reduction in btl > btl-RNAi animals
(Fig. 3d–f), indicating decreased insulin signaling, presumably
arising from blocked IPC DILP release. To determine whether the
observed reduction in insulin signaling was the direct cause of the
observed size phenotype, we asked whether rescuing circulating
insulin levels by overexpressing Dilp2 would also rescue growth.
Ubiquitous btl knockdown driven by armadillo-GAL4 (arm>) led
to reduced body size that was rescued by Dilp2 overexpression
(Fig. 3g), supporting that the size phenotype is caused by a
systemic reduction in insulin signaling downstream of Btl.
Alternatively, the observed reduced body size might involve
increased ecdysone signaling, which antagonizes insulin signaling
and suppresses larval body growth46. However, btl knockdown
led to reduced expression of the ecdysone-induced gene E75B,
which indicates reduced ecdysone-induced growth restriction
(Supplementary Fig. 3b). Together, these results suggest that the
reduced body size observed with btl knockdown is mediated by
effects in the tracheal system that lead to altered expression and
reduced secretion of DILP2, -3, and -5 from the IPCs, resulting in
reduced insulin-driven systemic growth.
btl RNAi leads to hypoxia via reduced tracheation. Hypoxic
tissues secrete the FGF-like ligand Bnl, inducing tracheal growth
toward these tissues via its receptor Btl. To assess whether btl
knockdown reduced tracheation of internal tissues, we observed
tracheal branches associated with the fat body in larval abdominal
segments 2 and 3 (Fig. 4a), quantifying the number of branches
and total tracheal length47. Control tracheae exhibited extensive
terminal branching, which was signiﬁcantly reduced in btl > btl-
RNAi animals, along with the total length of tracheal processes
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Fig. 1 In-vivo RNAi screen for factors regulating body size. a RNAi screen of 1845 genes of the Drosophila secretome and receptome selected by gene
ontology analysis. Upstream activating sequence (UAS)-inducible RNAi constructs against these genes were expressed ubiquitously using da-GAL4, and
pupal sizes were determined (data are presented in Supplementary Data 1). b, c Distribution of the pupal sizes from the screen (b) revealed 89 gene hits
that resulted in a signiﬁcant increase (c: blue, top) or decrease (c: orange, bottom) in body size (a Z-score > ± 2 was used as a cutoff) by comparison with
the mean of all lines. n= 9–55. d Genes and pathways identiﬁed in the screen having known size-regulatory function, as well as breathless (btl), are marked
with arrows. Error bars indicate SEM. Underlying data are provided in Supplementary Data 1
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(Fig. 4b, c), implying a reduced oxygen supply. In btl > btl-RNAi
animals, we observed strong upregulation of bnl (Fig. 4d), which
is induced in response to hypoxia29, indicating that internal tis-
sues were indeed experiencing hypoxia. We rationalized therefore
that these animals would be sensitized to low-oxygen conditions.
To test this, we reared control and btl > btl-RNAi animals under
hypoxic conditions (5% O2 vs. the normal 21% atmospheric level)
and measured their survival to the pupal stage. Most control
animals survived this environment, reﬂecting their ability to
adapt to reduced oxygen levels, whereas none of the btl-RNAi
animals survived to pupariation (Fig. 4e), presumably dying from
hypoxia-induced damage. Taken together, our data suggest that
the insulinergic changes described above operate downstream of
tissue hypoxia to adapt growth to oxygen availability.
To investigate whether insulinergic changes might regulate the
tracheae themselves, we assessed the effects of altering insulin
signaling in these tissues. Although overexpression of Dilp2
rescued growth of arm > btl-RNAi animals (Fig. 3g), it did not
restore the growth of their tracheae (Supplementary Fig. 3c).
Furthermore, tracheal knockdown of InR or Akt had no effect on
systemic growth or pupal size, whereas loss of Tor signaling in the
tracheae led to a strong reduction in size (Supplementary Fig. 3d).
Thus, our ﬁndings place insulin downstream of the growth of the
tracheal system and oxygen levels, mediating their effects on
systemic growth.
Hypoxia pathway activation mimics loss of btl. Thus, ubiqui-
tous or trachea-speciﬁc loss of btl induces internal tissue hypoxia,
which via reduced insulin signaling leads to reduced organismal
growth. To conﬁrm that hypoxia per se is the cause of this
reduction and to assess whether this inhibition is part of an
adaptive response rather than a pathological result of low oxygen
levels, we investigated the effects of external hypoxia on larval
growth. Wild-type (w1118) animals reared under 5% O2 displayed
reduced pupal size, despite a delay in pupariation that extended
the larval growth period, phenocopying btl > btl-RNAi and indi-
cating strong growth reduction (Fig. 5a, b, Supplementary
Fig. 4a).
The signaling pathway that transduces oxygen levels to induce
cellular adaptation is conserved between Drosophila and mam-
mals. The main effector protein of this pathway is the
transcription factor HIF-1a, encoded in Drosophila by the gene
similar (sima)48. Under normoxic conditions, this protein is
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Fig. 2 Tracheal loss of breathless reduces systemic growth and body size. a, b Quantiﬁcation of pupal sizes and representative images (b) of animals with
ubiquitous knockdown of breathless (btl)-pathway components compared with the controls (da >+; da > crossed to wild type, w1118). Values are percent
change in pupal size vs. control. a: n= 31–64. c Knockdown of btl in whole animals (da > btl-RNAi) or tracheae alone (btl>), but not in neurons (elav>),
muscle (Mef2>), fat-body tissue (ppl>), or glia (repo>) leads to small animals compared with da >+ controls. Shown also is the RNAi control (btl-RNAi/+ ;
btl-RNAi crossed to w1118). Values are percent change in pupal size vs. the btl >+ controls (btl > crossed to w1118). n= 33–86. d Trachea-speciﬁc knockdown
of btl reduces larval growth rates compared with driver (btl >+ ) and RNAi controls (btl-RNAi/+ ). Statistics: one-way ANOVA with Dunnett’s multiple-
comparisons test. ***P < 0.001, compared with the control. Error bars indicate SEM. Underlying data are provided in the Source Data ﬁle
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marked for proteasomal degradation through the oxygen-
dependent activity of Hph, also called Fatiga (Fga) in
Drosophila49,50. To differentiate between pathological damage
vs. a genetic adaptive response, we activated the hypoxia-
adaptation program by mutation of Hph, thus de-repressing
Sima under normoxic conditions. Similar to hypoxia or btl
knockdown, loss of Hph function resulted in growth inhibition
and developmental delay despite the animals’ normoxic environ-
ment (Fig. 5a, b, Supplementary Fig. 4a), conﬁrming the genetic
control of the growth phenotype.
To evaluate whether the insulin-related changes seen in btl-
knockdown animals are part of a genetic hypoxia-adaptation
program, we measured Dilp expression and DILP retention
within the IPCs in hypoxic wild-type animals and in normoxic
Hph mutants. Dilp3 and Dilp5 transcription was strongly reduced
in both manipulations (Fig. 5c). Furthermore, both conditions led
to increased IPC DILP2 and DILP5 retention (Fig. 5d). The
observed DILP3 level may represent retention of this protein as
well, as Dilp3 expression is greatly reduced by up to 90%. To
conﬁrm IPC DILP retention, we expressed epitope-tagged
DILP251 in these cells using Dilp2-GAL4 (Dilp2>) and measured
levels of circulating tagged insulin by enzyme-linked immuno-
sorbent assay (ELISA). Starvation conditions, known to reduce
hemolymph DILP2 levels52, greatly reduced tagged DILP2 titer
(Fig. 5e). However, feeding animals moved to hypoxia showed an
even stronger decrease in insulin release. Thus, hypoxia indeed
blocks DILP release from the IPCs. Consistent with decreased
systemic insulin signaling, both the low-O2 environment and Hph
loss led to reduced pAkt levels (Fig. 5f, Supplementary Fig. 4b).
We further investigated this using an in-vivo insulin-pathway
reporter that reﬂects intracellular insulin-pathway activity based
on plasma-membrane localization of green ﬂuorescent protein
(GFP)53. Under normoxia GFP was localized to the membrane of
fat-body cells, indicating active insulin signaling, whereas under
hypoxia, the reporter remained cytoplasmic, conﬁrming reduced
signaling (Fig. 5g).
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Similar to animals with btl knockdown, hypoxic wild-types and
normoxic Hph mutants exhibited reduced ecdysone signaling
(measured as expression of E75B) and upregulation of bnl
(Supplementary Fig. 4c, d). To rule out ecdysone deﬁciency as an
underlying cause of the hypoxic growth effect, we supplemented
wild-type animals with ecdysone by feeding and found that this
treatment even further decreased pupal sizes under hypoxic
conditions (Supplementary Fig. 4e), demonstrating that reduced
ecdysone does not underlie hypoxia-induced growth restriction.
Taken together, these ﬁndings are consistent with an underlying
phenomenon common to btl knockdown, hypoxic wild-types,
and normoxic Hph mutants—namely, the activation of the
genetic hypoxia-adaptation program that limits growth by
reducing insulin signaling.
Loss of btl or low O2 cause adipose-tissue hypoxia. The fat body
is reported to secrete factors that modulate IPC insulin expression
and release9–11,14–17. To investigate whether this tissue is also
involved in hypoxia adaptation, we ﬁrst measured fat-body bnl
transcription under tracheal btl knockdown and observed strong
elevation, indicating that this tissue experiences hypoxia with
tracheal insufﬁciency (Fig. 6a). To conﬁrm this hypoxic state, we
made use of a genetic hypoxia indicator based on GFP fused with
the oxygen-dependent degradation domain (ODD) of HIF-1a54.
Under normoxic conditions, this GFP-based reporter is degraded
through Hph activity, whereas red ﬂuorescent protein (RFP)
expressed from the same regulatory sequences acts as a ratio-
metric control. In the fat body, the GFP::ODD reporter was
rapidly degraded under normoxia, leading to a low GFP:RFP ratio
(Fig. 6b, Supplementary Fig. 5a). In contrast, an increased ratio
was observed in animals reared under 5% O2, indicating reduced
oxygen-dependent degradation of the ODD-linked GFP. Toge-
ther, these data show that the fat body experiences physiologically
signiﬁcant oxygen stress under our manipulations.
An adipose-derived hypoxia signal represses insulin release. We
next asked whether the brain and the IPCs alone could sense
hypoxia and induce changes in insulin physiology, or whether the
fat body might be necessary for organismal growth adaptation to
hypoxia. To investigate this, we cultured larval brains alone or with
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fat bodies for 16 h ex vivo under normoxia or hypoxia and assessed
the insulin-related effects of these manipulations (Fig. 6c). Whereas
hypoxic larvae exhibit reduced Dilp3 and -5 expression (Fig. 5c), we
observed no decrease in insulin-gene expression in brains cultured
alone under hypoxia vs. normoxia (Fig. 6d). Brains co-cultured with
fat bodies, however, did exhibit reduced Dilp expression under
hypoxia compared with normoxic cultures. These observations
demonstrate that the brain alone is insufﬁcient for hypoxia adap-
tation, and that a humoral signal(s) from the fat body regulates
Dilp3 and -5 expression as part of this response.
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To conﬁrm the requirement of fat-body genetic hypoxia
responses for DILP2 retention, we cultured wild-type brains
either alone or with wild-type or Hph-mutant fat bodies, under
normoxia and hypoxia. Co-culturing wild-type brains and fat
bodies under normoxia induced a drop in DILP2 retention
compared with brains alone, consistent with previous studies
showing that the fat body releases humoral signals that promote
insulin secretion in well-fed animals reared under normal oxygen
conditions9,12,16,55. Brains cultured alone did not exhibit DILP2
changes between hypoxia and normoxia; however, when brains
were cultured with wild-type fat-body tissue, hypoxia strongly
induced DILP2 retention (Fig. 6e). These changes indicate that
hypoxia-induced inhibitory fat-body factor(s) are required for
insulin retention. To assess the genetic control of this signal, we
co-cultured wild-type brains with Hph-mutant fat bodies under
normoxia (Fig. 6f) and found again that DILP2 was retained in
the IPCs.
Next, as this fat-body oxygen sensor regulates insulin
physiology, we wished to examine its necessity in the regulation
of systemic growth. To ensure efﬁcient gene-activity disruption,
we made UAS-inducible CRISPR/Cas9 constructs to delete
Hph speciﬁcally in the fat tissue. Under normoxia, pupal size
was strongly reduced by fat-body-speciﬁc disruption of Hph,
driven by either of two independent fat-body-GAL4 lines (Fig. 6g),
similar to the size reduction observed with hypoxia or traditional
Hph mutation. Furthermore, we found that deletion of Hph in
the fat body led to reduced Dilp3 transcription and to DILP2
retention in the brain (Fig. 6h, i) under normoxia. Fat-body-
speciﬁc Hph knockout therefore recapitulates major components
of the organismal hypoxic response. Taken together, these results
indicate that the activity of the Hph-regulated hypoxia-adaptation
program within the fat body is the determinant, via secreted
inhibitory factor(s), of IPC insulin retention and thereby of
systemic growth rate.
Hph is required for Tor activity, independently of HIF-1a.
Beyond its role in coupling oxygen to systemic growth demon-
strated above, the fat body also links intake of dietary AAs to
systemic growth through a Tor-dependent nutrient-sensing
mechanism that regulates release of insulin-governing factors.
We therefore next explored the possible relationships between
oxygen and AA sensing in growth regulation. We reared wild-
type animals and Hph and sima mutants56 on foods containing
0.1×, 0.3×, or 1× (standard food) concentrations of yeast (the
customary dietary protein source) under normoxia or 5% O2 and
assessed the animals’ growth responsiveness to dietary protein.
Whereas wild-type animals displayed a robust scaling of body size
to dietary protein levels under normoxia, hypoxia attenuated
or blocked this response (Fig. 7a). Similarly, inducing genetic
hypoxic responses by Hph mutation rendered animals growth-
unresponsive to protein even under normoxia, indicating that
normal growth responses to dietary AAs require Hph signaling.
To address whether this effect requires HIF-1a, we analyzed the
growth response of HIF-1a/sima mutants to dietary protein.
Under normoxic conditions, sima-mutant animals responded
to dietary AAs to the same degree as wild types. Thus, unlike
Hph, Sima is not required for AA-dependent growth regulation.
However, in contrast to wild-type animals, sima mutants still
responded to dietary protein even under hypoxic conditions, and
their hypoxia-induced size reduction was signiﬁcantly rescued
(Fig. 7a), indicating that Sima is required for hypoxia-induced
growth restriction.
As a number of known growth-regulatory factors released by
the fat body are regulated by Tor activity in response to AA
availability10,11,16,17, we investigated whether Tor signaling might
be altered by hypoxia, and, if so, how AA levels and Hph and
Sima/HIF-1a activity affected this alteration. We reared wild-type
animals on standard 1× food in normoxia and hypoxia, and
measured levels of phosphorylated ribosomal protein S6 (pS6), a
downstream effector and proxy for Tor signaling57, in the fat
bodies of feeding late-third-instar larvae. Hypoxic rearing very
strongly reduced pS6 levels (Supplementary Fig. 5b), indicating
that constitutive hypoxia induces a large reduction in Tor activity.
We next measured levels of pS6 in wild-type animals and Hph
and sima mutants, under normoxia or 16 h hypoxic conditions,
with and without 16 h AA starvation. Wild-type animals kept
on standard 1× food under normoxia exhibited high levels of
pS6, indicating strong Tor activity (Fig. 7b), and 16 h hypoxia
treatment led to a decrease in pS6 staining, as did AA starvation,
which is known to inhibit Tor. Combining these treatments,
hypoxia and AA starvation, did not further reduce fat body pS6
levels beyond that of starvation alone, suggesting either that they
act through the same pathway or that Tor is already maximally
inhibited by protein starvation.
Hph-mutant animals exhibited low fat-body pS6 staining that
was not affected by oxygen or AA levels. This is consistent with
the hypoxic response as well as the lack of growth response
of Hph mutants to dietary AAs, indicating that Hph activity
is required for Tor-pathway function. A known feedback loop
connects HIF-1a/Sima to Tor inhibition58,59, so we next
investigated whether Sima is required for hypoxia-induced Tor
inhibition. In contrast to loss of Hph, animals lacking sima still
exhibited high levels of Tor activity under standard food and
normoxic conditions, indicating that Sima is not required for
Tor activity in these conditions. Furthermore, these animals also
retained Tor inhibition under restrictive conditions of oxygen or
AA deﬁciency (or both), indicating that Sima is not required for
Tor inhibition in these situations. Therefore, oxygen-regulated
Hph activity, but not Sima activity, is required for Tor activity
and response to AAs.
To assess the physiological signiﬁcance of Tor activity in the fat,
we measured the size of lipid droplets (LDs), a parameter thought
to reﬂect Tor activity55, under the same environmental conditions
as above. LDs of wild types were relatively small and their sizes
increased under hypoxia or AA starvation (Fig. 7c), consistent
with the reduced Tor activity observed under these conditions
(Fig. 7a). On the other hand, loss of Hph led to greatly enlarged
LDs in the fat body and their size was not further altered by
hypoxia or AA starvation, consistent with the data above that
suggest that Hph is required for transducing these signals through
a Tor-dependent mechanism. Both hypoxia and AA starvation
still led to increased LD size in sima mutants, indicating that
Sima activity is not required for these effects, consistent with
the ﬁnding that these animals also inhibit Tor appropriately in
response to AA starvation and hypoxia. Thus, the Hph-dependent
and HIF-1a/Sima-independent Tor-activity differences observed
under varied environmental and genetic perturbations lead to
physiological changes in fat distribution within the fat body.
As our data indicate that Tor-dependent AA responses require
Hph activity, we next tested directly whether Hph might be
involved in sensing AA levels, using the GFP::ODD Hph-activity
reporter construct, and observed that 4 h protein starvation led
to a signiﬁcant increase in fat-body GFP::ODD perdurance
(Fig. 7d). As Hph activity targets ODD-containing proteins for
destruction, this result suggests that Hph activity is reduced by
insufﬁciency of AAs as well as of oxygen. Thus, both AAs and
oxygen may induce growth through modulating Hph activity,
which is required for growth.
As our data suggest that both AAs and oxygen affect Tor
through Hph, and Tor in the fat body is known to regulate the
release of factors that control DILP secretion, we wished to
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determine whether Tor activity per se might contribute to
observed hypoxia-induced growth effects. We therefore stimu-
lated the Tor pathway in the fat body by expressing the activator
Rheb (ppl > Rheb). Although this manipulation dramatically
increased Tor activity under hypoxia, it did not rescue the size
phenotype (Supplementary Fig. 6a, b), indicating that the size-
regulatory effects of hypoxia do not arise from alteration of Tor
activity in the fat body. To further conﬁrm the Tor independence
of hypoxic growth reduction, we assessed the effects of individual
known Tor-regulated growth modulators. Of the known fat-
body-derived factors, Egr is the only one that is reported to be
insulinostatic, although its speciﬁc effects do not exactly match
those we observed under hypoxia17. We expressed RNAi against
egr in the fat body or against the gene encoding its receptor,
Grindelwald (Grnd), in the IPCs. Consistent with the idea of a
Tor-independent mechanism, we found that neither egr nor grnd
RNAi rescued the low-oxygen body-size reduction, suggesting
that they do not play a role in hypoxia-induced growth restriction
(Supplementary Fig. 6b). We also assessed other fat-body-derived
factors and their receptors such as CCHa-2, Sun, GBPs 1 and 2,
and Daw, although these are reported to be growth-promoting
factors, to rule out their involvement. None of these factors
appears to affect hypoxia-induced growth restriction. Thus, the
factor released by the fat body appears to be a previously
uncharacterized Tor-independent signal that is released down-
stream of Hph and HIF-1a/Sima as an inhibitor of insulin
secretion.
Hypoxia reduces systemic growth via HIF-1a in the fat body.
As the data above suggested that HIF-1a/Sima is required in the
fat body for hypoxia-adaptation effects on body size, we investi-
gated the effects of fat-body-speciﬁc manipulations of HIF-1a/
Sima function. First, we examined whether fat-body-speciﬁc
RNAi against sima could block the DILP retention induced by
hypoxia. We observed a small but signiﬁcant reduction in IPC
DILP2 levels and partial rescue of the hypoxia-induced growth
inhibition with this manipulation (Supplementary Fig. 6c, d),
which might indicate weak knockdown. Therefore, we repeated
this experiment using tissue-speciﬁc CRISPR/Cas9-mediated
disruption of sima and observed a much stronger reduction in
IPC DILP2 levels under hypoxia (Fig. 8a). Furthermore, Dilp3
d
a b
Dilp3
R
el
at
iv
e 
ex
pr
es
si
on
0
10
20
30
40
Δ 
S
iz
e 
(%
)
pp
l>C
as9
/+
UA
S-s
ima
KO /+
pp
l>C
as
9, 
sim
aK
O
***
5% O2 5% O2 5% O2
ppl>Cas9/+
ppl>Cas9, simaKO
ppl>Cas9/+
ppl>Cas9, simaKO
α-DILP2
c
N
or
m
al
iz
ed
 fl
uo
re
sc
en
ce
Hph
Sima
(HIF-1a)
Tor
Lipid
mobilization
Tracheation
Fat body
Systemic growth
DILP release
Secreted
factor(s)
Branchless
(FGF)
Breathless
(FGFR)
BrainTrachea
AA
O2
0
1
2
***
0
100
200
300
400
*
Fig. 8 HIF-1a/Sima is required in the fat body for hypoxia-induced growth suppression. a–c Fat-body-speciﬁc loss of sima via tissue-speciﬁc CRISPR/Cas9-
mediated gene disruption reduces hypoxia-induced IPC DILP2 retention (a) and suppression of Dilp3 expression (b) and rescues hypoxia-induced
growth restriction (c). Statistics: Student’s t-test for pairwise comparisons and one-way ANOVA with Dunnett’s for multiple-comparisons test. *P < 0.05,
***P < 0.001, compared with controls (ppl > Cas9/+ and UAS-simaKO/+ ). Error bars indicate SEM. Underlying data are provided in the Source Data ﬁle.
a: n= 9. b: n= 6. c: n= 18–33. d Proposed model for integration of hypoxia and amino-acid sensing via the fat body and insulin regulation. Tracheation of
the fat body is regulated by the FGF ligand Branchless secreted from this tissue in response to local tissue hypoxia, triggering tracheal outgrowth via the
FGF receptor Breathless. When the tracheal system is unable to deliver sufﬁcient oxygen because of environmental oxygen levels or body growth, Hph is
unable to trigger the degradation of Sima/HIF-1a, which induces the expression or release of one or more humoral factors from the fat tissue that act on the
insulin-producing cells (IPCs) to downregulate Dilp transcription and to block DILP release. Through a separate pathway, Hph inhibition also blocks Tor
activity in the fat body, which alters lipid distribution. Hypoxia thereby reduces circulating insulin through activation of a central oxygen sensor in the
fat tissue, which slows the growth of the whole organism. During these low-oxygen conditions, secretion of Branchless from the fat tissue promotes
insulin-independent growth of the tracheal airways to increase oxygen supply. This system allows the organism to adapt its metabolism and growth to
limited-oxygen conditions by reducing overall body growth through downregulation of insulin signaling, while at the same time promoting development of
the tracheal system to maintain oxygen homeostasis
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09943-y ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1955 | https://doi.org/10.1038/s41467-019-09943-y | www.nature.com/naturecommunications 11
transcription was de-repressed (Fig. 8b) and the hypoxia-induced
body-size reduction was signiﬁcantly rescued by knockout of
sima in the fat body (Fig. 8c). Taken together, our data show that
fat-body HIF-1a/Sima activity is required for hypoxia-induced
suppression of body growth via humoral signaling from the fat
that inhibits insulin secretion.
Discussion
In this report, we identify one tissue in particular, the fat body,
which senses internal oxygen levels and regulates growth rate
accordingly. Our data show that, as an adaptive response to
oxygen limitation, the fat tissue releases into the circulation one
or more factors that inhibit the secretion of insulin from the brain
to reduce systemic growth (Fig. 8d). We demonstrate that the
ability of oxygen to reduce systemic body growth through
downregulation of insulin signaling requires Hph-dependent
HIF-1a/Sima activity in the fat tissue. Furthermore, we show that
hypoxia and AA deprivation both reduce Hph activity in the fat
tissue, and that this reduction leads to suppression of Tor sig-
naling, independently of HIF-1a/Sima. This is consistent with a
requirement of Hph for cell growth49. In other contexts, Sima is
known to regulate Tor-pathway activity via the protein Scylla/
REDD158,59. However, this pathway does not appear to be
responsible for the effects of hypoxia on Tor activity observed
here, as sima mutation does not block hypoxia- or starvation-
induced Tor suppression. Likewise, Tor suppression is not
necessary for the systemic growth reduction induced by hypoxia.
Our data suggest that Hph is involved in AA sensing, in addition
to its well-described role in oxygen sensing, and that HIF-1a is
not involved in this process. Together, this suggests that AA and
oxygen sensing converge through Hph in the fat body to mod-
ulate systemic growth in response to environmental conditions.
Many of the known Drosophila adipokines that affect insulin
secretion from the IPCs are regulated by Tor-pathway activity
in the fat body, including CCHa-210, Egr17, FIT11, GBP1 and
GBP212, and Sun16. Our ﬁnding that AA availability regulates
Hph activity, and that Hph activity modulates Tor signaling, thus
places Hph upstream of these known factors, in addition to the
separate Sima-dependent and Tor-independent humoral factor(s)
that modulate insulin secretion under hypoxia. Several routes
by which AA availability regulates Tor have been investigated49
and Hph may modulate some of these and not others, thereby
allowing for different responses to AA starvation and hypoxia.
Indeed, our work shows that HIF-1a/Sima is required for the
growth-suppressive effect of hypoxia, but not for growth
responses to varied dietary AA input, although Hph is involved in
both. The mechanisms by which Hph activity, which simulta-
neously requires AAs and oxygen, allows or promotes Tor sig-
naling is an interesting topic to investigate in future studies,
as is the identity of the Tor-independent humoral factor(s)
downstream of Sima.
Our results show that hypoxia or loss of fat-body Hph activity
Sima dependently represses Dilp3 and Dilp5 transcription, while
having little or no suppressive effect on Dilp2 expression. This
suggests that speciﬁc transcriptional regulation of Dilp3 and Dilp5
is an important component of the response to hypoxia. Con-
sistent with this observation, previous studies have shown that the
transcription of Dilp2, -3, and -5 are independently regulated7.
Nutrient deprivation reduces expression of Dilp3 and -5, while
having no effect on Dilp2 expression, similar to the effects of
exposure to hypoxia. This is consistent with our ﬁnding that both
AA deprivation and hypoxia suppress Hph activity, although the
downstream pathways involved appear likely to be different, as
at least some aspects of nutrient deprivation are relayed through
the Tor pathway, whereas the hypoxia-speciﬁc signal(s) shown
here is not. This observed transcriptional response could con-
ceivably arise secondarily to DILP-release inhibition via autocrine
feedback regulation that operates in both Drosophila and
mammals60,61. However, lower secretion of DILPs, which we
observe under hypoxic conditions, generally feeds back to
induce an increase in the expression of Dilp3 and -5 rather than
the decrease that we observe. Therefore, the hypoxia-induced
alterations of Dilp3 and -5 expression appear to be speciﬁc
transcriptional responses rather than feedback effects. Thus,
beyond the identity of the fat-body factor involved, the
mechanisms operating in the IPCs by which it regulates insulin-
like gene expression and peptide release will be important to
study in future experiments.
In mammals, several adipokines regulate β-cell function and
insulin secretion, including Leptin, which conveys information
about fat storage and is a functional analog of the Drosophila
fat-derived cytokine Unpaired-29,62. Interestingly, we observed
strong increases in fat-body LD size induced by Tor inhibition
downstream of AA starvation, hypoxia, or Hph mutation, indi-
cating a change in lipid metabolism within the fat tissue.
Although this phenotype is Tor-dependent and not upstream of
the particular HIF-1a-dependent factor described above, it is
possible that additional signals related to lipid metabolism may
be released by the fat body in response to hypoxia or starvation,
such as a lipid-binding protein or even a lipid per se. For example,
the mammalian fatty acid-binding protein 4 is an insulin-
modulating adipokine that is inﬂuenced by obesogenic conditions
that lead to adipose tissue hypoxia63, and orthologous proteins
are encoded by the Drosophila genome.
Most organisms stop growing after reaching a genetically
predetermined species-characteristic size. Although insight from
genetic studies in Drosophila1,6,12,16,17,55 into the mechanisms
that regulate body growth with regard to nutrition helps to
explain how organisms modulate their growth rate according
to nutritional conditions, a mechanism that allows organisms to
assess their size and stop their growth when they have reached an
optimum has remained elusive. However, recent evidence sug-
gests that body size in insects may be determined by a mechanism
that involves oxygen sensing3, and oxygen availability is known to
place limits on insect body size18,20–22. According to this recent
insight, the limited growth ability of the tracheal system during
development may limit overall body size via downstream oxygen
sensing3. The size of the tracheal system is established at the
beginning of each developmental stage and remains largely ﬁxed,
aside from terminal branching, as the body grows until it even-
tually reaches the limit of the system’s ability to deliver oxygen.
This allows the body to assess its size by sensing internal oxygen
concentrations and to terminate growth at a characteristic size
that is determined by the size of the tracheal system. Our RNAi
screen shows that the FGF receptor Btl, which is a key factor
essential for tracheal growth during development, is a main
determinant of body size—indeed, btl was a stronger hit than
known size-governing genes—and our data therefore support the
notion that the tracheal system and oxygen sensing may be part
of a size-assessment mechanism.
Oxygen homeostasis also requires the coordination of growth
between the tissues that consume oxygen and those that deliver it.
The development of the oxygen delivery system is therefore oxygen
sensitive in both mammals and Drosophila. In mammals, local
tissue hypoxia promotes angiogenesis via induction of many pro-
angiogenic factors, including FGF64. In Drosophila, tissue hypoxia
induces expression of the FGF-like ligand Bnl, leading to branching
of the tracheal airway tubes toward oxygen-deﬁcient areas29,65.
Our study shows that this mechanism operates independently of
insulin, as reduced insulin signaling in the trachea has no effect on
overall body growth. This system therefore allows an adaptive
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response to low oxygen by reducing overall body growth via
suppression of insulin signaling, while promoting hypoxia-induced
FGF-dependent tracheal growth to increase oxygen delivery.
Cell and tissue hypoxia are also observed in human conditions
of obesity and cancer. The insect fat body performs the functions
of mammalian fat and liver tissues. Accordingly, perturbation of
systemic insulin signaling by adipose and hepatic tissue hypoxia
is also observed in mammalian systems66. In mammals, obesity
induces hypoxia within adipose tissue due to the rarefaction of
vascularization of this tissue67, leading to the release of inﬂam-
matory mediators and other adipokines that are associated with
the pathophysiology of obesity-related metabolic disorders
including diabetes68–73. Although loss of normal β-cell activity
is considered a main factor in diabetes, the mechanism by which
tissue hypoxia affects insulin secretion is poorly understood.
Our ﬁnding of one or more hypoxia-induced fat-body-derived
insulinostatic factors may lead to insights into the role of adipose-
tissue hypoxia in obesity and its impact on diabetes. Furthermore,
we show a link between oxygen and AA availability in the adipose
tissue through Hph-dependent regulation of the Tor pathway,
linking these pathways in a common metabolic response to
oxygen limitation and nutrient scarcity.
Obesity also causes physical and hormonal changes that affect
breathing patterns, leading to apnea and thus intermittent epi-
sodes of systemic hypoxia74. These hypoxic periods can induce
changes in the liver, leading to fatty liver disease and dyslipide-
mia. The alterations to fat-body lipid metabolism observed here
may thus be relevant to human health as well. Furthermore,
hypoxia-induced programs play important roles in tumor for-
mation. During cancer development, tumor cells undergo a
metabolic reprogramming, the so-called Warburg effect, in which
their metabolism shifts from oxidative phosphorylation to gly-
colysis75, and activation of HIF-1a is believed to play a key role in
this shift. As the hypoxia-sensing mechanism and the insulin-
signaling system are conserved between ﬂies and mammals,
understanding the effects of hypoxia on the fat body could thus
provide insight into many human disease states. It will be of
interest to study whether tissue hypoxia also inhibits Tor-pathway
activity in mammalian adipocytes.
In conclusion, our study unravels a mechanism that allows
organisms to adapt their metabolism and growth to environments
with low oxygen. Hypoxia activates a fat-tissue oxygen sensor that
remotely controls the secretion of insulin from the brain by inter-
organ communication. This involves the inhibition of Hph
activity, leading to the activation of a HIF-1a-dependent genetic
program within the fat tissue, which then secretes one or more
humoral signals that alter insulin-gene expression and repress
insulin secretion, thereby slowing growth. We also show that AA
scarcity, like oxygen deﬁciency, inhibits Hph activity, and that the
activity of Hph, but not of HIF-1a, is required for Tor activity in
the fat body. Thus, in addition to its role in regulating the as-yet
unidentiﬁed fat-body hypoxia signal via HIF-1a, Hph connects
both oxygen and AA levels to the Tor pathway through an
unknown HIF-1a-independent mechanism. Given the conserva-
tion of oxygen-sensing and growth-regulatory systems, and the
inﬂuence of oxygen on growth between Drosophila and mam-
mals, a similar adaption response may operate in mammals via
adipose tissue oxygen sensing to maintain homeostasis.
Methods
Fly strains and husbandry. Unless speciﬁed otherwise, animals were reared on
standard cornmeal-yeast medium (Nutri-Fly, Bloomington recipe) at 25 °C and
60% relative humidity, under a 12L:12D light cycle. The 1× yeast diet contains 34 g
baker’s yeast, 6 g agar, 60 g sucrose, 84 g cornmeal, 4.8 mL propionic acid, and 1.6 g
Tegosept/Nipagin antifungal agent (in 16 mL 100% ethanol) per liter. Restric-
ted (0.1× and 0.3×) diets contain 3.4 g/L or 10 g/L yeast, respectively, with all other
components held constant. Sugar-only diet contains no cornmeal or yeast with
other components held constant. The AkhR-GAL4::p65 transgene containing the
enhanced activator GAL4::p6576 drives very strongly in the larval fat body. The
GAL4::p65 was recombineered into genomic bacterial artiﬁcial chromosome con-
struct CH322-147J1777 obtained from Children’s Hospital Oakland Research
Institute (Oakland, CA, USA), replacing the ﬁrst coding exon, and the construct
was integrated into the attP2 genomic site by standard injection methods. The
following stocks were obtained from the Bloomington Drosophila stock center:
arm-GAL4 (#1560), btl-GAL4 (#41803), Cg-GAL4 (#7011), da-GAL4 (#55850),
elav-GAL4 (#458), Mef2-GAL4 (#27390), ppl-GAL4 (#58768), R96A08-GAL478
(#48030), repo-GAL4 (#7415), simaKG07607 (sima null)56 (#14640), tGPH insulin-
activity sensor53 (#8164), UAS-Cas9.P2 (#58986), UAS-CCHa2-RNAi (#57183),
UAS-CCHa2-R-RNAi #2 (#25855), UAS-eiger-RNAi (#58993), UAS-InR-RNAi
(#992), UAS-methuselah-RNAi #1 (#27495) and #2 (#36823), UAS-methuselah-like-
10-RNAi #1 (#62315) and #2 (#51753), UAS-sima-RNAi (#26207), UAS-TorTED
(Tor dominant negative; #7013), and UAS-Tsc1/2 and UAS-VALIUM10-Luciferase
(#35789). Vienna Drosophila Resource Center (VDRC) RNAi lines used for follow-
up studies include UAS-Akt-RNAi (#103703), UAS-bnl-RNAi (#101377), UAS-btl-
RNAGD950 (#950), UAS-btl-RNAiGD27108 (#27108), UAS-CCHa2-R-RNAi #1
(#100290)10, UAS-grnd-RNAi #1 (#104538)17 and #2 (#43454)17, UAS-sima-RNAi
(#106187), UAS-daw-RNAi (#105309), and UAS-Stunted-RNAi (#23685)16. HphΔ9
(fatigaΔ9, fgaΔ9)56 was a kind gift of P. Wappner (Instituto Leloir), ubi-GFP::ODD
hypoxia sensor (more rigorously, Hph-activity sensor)54 was a kind gift of S.
Luschnig (U. Münster), and UAS-FLAG::Dilp279 and UAS-RhebEP50.084,w-/TM6B,
Tb80 were gifts of E. Hafen and H. Stocker (ETH Zürich). UAS-DILP2HF51 was a
kind gift from S. Park and S. Kim (Stanford). The common laboratory stock w1118
from VDRC (#60000) was used as a control in many experiments.
RNAi screen for pupal size. A list of genes encoding the secretome (secreted
proteins) and receptome (membrane-associated proteins) was generated using
ENSEMBL and GLAD gene ontology databases. UAS-RNAi lines against 1845
genes for the screening of the secretome and receptome were obtained from the
Bloomington Drosophila stock center32 and the VDRC31, and transformant IDs
are given in Supplementary Data 1. Males from each RNAi line were crossed to
da-GAL4 virgin females, animals were allowed to lay eggs for 24 h, and the average
size of pupal offspring was determined from images acquired with a Point Grey
Grasshopper3 camera using a custom script in MATLAB (The MathWorks, Inc.,
Natick, Massachusetts, USA)81. Each line was given a Z-score, calculated as the
number of SD between that line’s average and the average of all lines. Lines with
a Z-score between −2 and 2, corresponding in this data set roughly to a ±15%
size abnormality, were not analyzed further, whereas 89 lines with greater effect
were identiﬁed.
Generation of tissue-speciﬁc CRISPR lines. To generate lines for tissue-speciﬁc
CRISPR-based deletion of Hph and sima/HIF-1a, double guide RNAs were cloned
into plasmid pCFD682,83 (Addgene #73915). The Hph construct should lead to the
deletion of part of the genomic region encoding the dioxygenase domain common
to all Hph isoforms, and the sima gRNAs target the region encoding that protein’s
DNA-binding domain. The Cas9 target sequences below were synthesized as part
of long oligonucleotides that were used to amplify gRNA structural sequences from
pCFD6 using Q5 polymerase (New England Biolabs, #M0491S); plasmid template
DNA was then removed by DpnI digestion (NEB, #R0176S). pCFD6 was linearized
by BbsI digestion (NEB, #R3539S) and treated with alkaline phosphatase (NEB,
#M0290S) to prevent self-ligation. The PCR products were recombined into the
linearized, phosphatase-treated vector by Gibson assembly using the NEBuilder
HiFi DNA Assembly Master Mix (NEB, #E2621S). Clones were analyzed by PCR
and sequence conﬁrmed. pCFD6-UAS-HphKO and pCFD6-UAS-simaKO were
integrated into landing site attP2 (third chromosome) in-house and by BestGene
(Chino Hills, CA) using standard methods. To remove fatiga or sima function
in the fat body, two CRISPR-driver stocks—ppl-GAL4; UAS-Cas9.P2/TM6B, Tb
and Cg-GAL4; UAS-Cas9.P2/TM6B, Tb—were made, and these were crossed to the
UAS-gRNA lines generated above, or to w1118 as a driver control. The Cas9.P2
variant used here is somewhat weak, so to increase Cas9 expression by increasing
GAL4 activity, we incubated the offspring at 30 °C. Hph target sites: 5′-
GTATCGTGTTAACACGATGA-3′ and 5′-GAATATCAACTGGGATGCGC-3′;
sima target sites: 5′-GGCTAGATGTCGTCGCTCCA-3′ and 5′-GGCTA-
GATGTCGTCGCTCCA-3′.
Tracheal measurements and hypoxic survival rates. To determine tracheal
length and branching, L3 larvae [96 h after egg lay (AEL) for control; 120 h for btl-
RNAi animals to account for slowed growth] were heat-ﬁxed in a drop of glycerol
on a microscope slide on a 60 °C heat block until they became relaxed. Tracheal
cells and branching of the fat-body terminal branches were visualized in whole
larvae by imaging of tracheae labeled with GFP or by direct light microscopy.
Length and branching were manually quantiﬁed using the FIJI (NIH) software
package. To determine survival rates of btl knockdown animals, timed egg lays
were performed, and ﬁrst-instar (L1) larvae were transferred to ﬂy vials containing
standard food and incubated in either hypoxia (5% O2) or normoxia (21% O2,
normal atmospheric oxygen concentration), and the number of animals surviving
to the pupal stage was determined. The low-oxygen environment was generated by
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slowly passing 5% O2+ 95% N2 through a clear, airtight plastic chamber placed
inside a 25 °C, 12L:12D incubator. Gas was bubbled through water upstream and
downstream of the chamber, to provide humidity and to prevent inﬁltration of
outside air, and vented outside the incubator. The chamber was ﬂushed with high-
ﬂow-rate gas for 5 min after any opening.
Analysis of developmental timing and growth rates. To synchronize larvae for
growth rate and developmental-timing assays, ﬂies were allowed to lay eggs for 4 h
on apple-juice agar plates supplemented with yeast paste. Newly hatched L1 larvae
were transferred into vials with standard food (30 per vial to prevent crowding)
24 h later. To determine growth rates, synchronized larvae were weighed at time
points 75–96 h AEL in groups of 5–10 animals. For developmental-timing
experiments, pupariation time was determined manually.
Ex-vivo organ co-culture. For organ co-culture experiments, brains and fat
bodies were dissected from 96 h AEL wild-type w1118 larvae or 120 h AEL Hph-
mutant larvae (to adjust for their slow growth) in cold Schneider’s culture medium
(Sigma-Aldrich #S0146) containing 5% fetal bovine serum (Sigma). Fifty brains,
with or without fat bodies present, were incubated in 50 μL culture medium for
16 h at 25 °C in small dishes in moist chambers in either hypoxia or normoxia.
After incubation, brains were removed for immunostaining and quantitative real-
time PCR (qPCR) analyses.
Expression analysis by qPCR. To quantify gene expression by qPCR, mRNA was
prepared from samples of ﬁve whole larvae each (96 h AEL for btl > + controls and
normoxia animals, and 120 h AEL for btl-RNAi larvae, animals raised under
hypoxia, and Hph mutants to adjust for their slower growth) using the RNeasy
Mini Kit (Qiagen #74106) with DNase treatment (Qiagen #79254). RNA yield was
determined using a NanoDrop spectrophotometer (ThermoFisher Scientiﬁc), and
cDNA was generated using the High-Capacity cDNA Reverse Transcription Kit
with RNase Inhibitor (ThermoFisher #4368814). qPCR was performed using the
QuantiTect SYBR Green PCR Kit (Fisher Scientiﬁc #204145) and an Mx3005P
qPCR System (Agilent Technologies). Expression levels were normalized against
RpL32. FlyPrimerBank pre-computed oligo pairs were used for some target genes.
The primer pairs used are given in Supplementary Table 1.
Western blotting analysis. To quantify signaling pathway activity downstream of
InR, the level of Akt phosphorylation (pAkt) was determined by western blotting.
For hypoxia experiments, larvae were transferred to 5% O2 at 72 h AEL and
analyzed 24 h later, compared with 96 h AEL normoxic controls. Hph-mutant
larvae were assayed at 120 h AEL. For each sample, three larvae were homogenized
in SDS loading buffer (Bio-Rad), boiled for 5 min, centrifuged at 14,000 × g for
5 min to pellet debris, and electrophoresed through a precast 4–20% poly-
acrylamide gradient gel (Bio-Rad). Proteins were transferred to a polyvinylidene
diﬂuoride membrane (Millipore), and the membrane was blocked with Odyssey
Blocking Buffer (LI-COR) and incubated with rabbit anti-pAkt (Cell Signaling
Technology #4054, diluted 1:1,000) or rabbit anti-pan-Akt (Cell Signaling Tech-
nology #4691, diluted 1:1,000), and mouse α-Tubulin (Sigma #T9026, diluted
1:5,000) in Odyssey Blocking Buffer (LI-COR) containing 0.2% Tween 20. Primary
antibodies were detected with goat secondary antibodies—IRDye 680RD anti-
mouse (LI-COR #925-68070) and IRDye 800CW anti-rabbit (LI-COR #925-32210)
diluted 1:10,000—and bands were visualized using an Odyssey Fc imaging system
(LI-COR). Uncropped blots are presented in the Source Data ﬁle.
ELISA of circulating tagged DILP2. Dilp2 >DILP2HF51 animals were reared
under normal conditions until 24 h before wandering and then transferred to
starvation medium (1% agar in water) in normoxia, to normal food under hypoxia
(5% O2), or back to normoxia and normal diet for 12 h. Hemolymph was
extracted by cutting the larval cuticle and pipetting the released droplet into
a collection vial. Collected hemolymph was heat-treated at 60 °C for 5 min, cen-
trifuged to remove any debris or aggregates, and used in an ELISA against the
HA and FLAG tags. F8 MaxiSorp Nunc-Immuno modules (Thermo Scientiﬁc
#468667) were incubated at 4 °C overnight with 5 μg/mL anti-FLAG (Sigma-
Aldrich #F1804) in 200 mM NaHCO3 buffer (pH 9.4). After two washes with
phosphate-buffered saline (PBS)+ 0.1% Triton X-100 (PBST), the plate was
blocked with PBST+ 4% non-fat dry milk for 2 h at room temperature and
washed again three times in PBST. One microliter of hemolymph or synthetic
HA::spacer::FLAG peptide standard (DYKDDDDKGGGGSYPYDVPDYamide)
was diluted into 50 μL PBST+ 25 ng/mL mouse anti-HA peroxidase (Roche
12013819001)+ 1% non-fat dry milk, added to the wells, and incubated overnight
at 4 °C. Fluid was removed and wells were washed in PBST six times. One-step
Ultra TMB ELISA substrate (Thermo Scientiﬁc #34028) was added to each well
(100 μL) and incubated for 15 min at room temperature. Sulfuric acid (2 M, 100
μL) was added to stop the reaction and absorbance at 450 nm was measured using
a plate reader. Plate, peptide standard, UAS-DILP2HF, anti-FLAG, anti-HA,
substrate, and detailed protocol were all generously provided by S. Park and
S. Kim (Stanford University).
Immunostaining. Brains were removed from ex-vivo cultures or dissected from
larvae 96 h AEL (normoxia) or 120 h AEL (hypoxia and Hph mutants) in cold
Schneider’s culture medium and ﬁxed in fresh 4% paraformaldehyde in PBS for
1 h. Tissues were washed four times in PBST (PBS containing 0.1% Triton X-100),
blocked with PBST containing 3% normal goat serum (Sigma-Aldrich #G9023)
at room temperature for 1 h, and incubated with primary antibodies overnight at
4 °C. The following primary antibodies were used: rat anti-DILP252 (kind gift of
P. Léopold, U. Nice) at 1:250 dilution; mouse anti-DILP3 at 1:200 dilution (kind
gift of J. Veenstra, U. Bordeaux); rabbit anti-DILP584 at 1:2,000 dilution (kind gift
of D. Nässel, U. Stockholm); rabbit anti-phospho-ribosomal pS6 (anti-pS6)57 at
1:200 (kindly given by A. Teleman, DKFZ). Tissues were washed three times in
PBST and incubated in secondary antibodies: goat anti-rabbit Alexa Fluor 488
(Thermo Fisher Scientiﬁc, #A32731), goat anti-rat Alexa Fluor 555 (Thermo Fisher
Scientiﬁc, #A21434), and goat anti-mouse Alexa Fluor 647 (Thermo Fisher Sci-
entiﬁc, #A28181), all diluted 1:500 in PBST, overnight at 4 °C. After four washes in
PBST, tissues were mounted in Vectashield (Vector Labs #H-1000) and imaged
using a Zeiss LSM 800 confocal microscope and Zen software. Retained insulin
levels were calculated using the FIJI software package.
Fat-body imaging. To measure in-vivo intracellular insulin-signaling transduction
in the fat body, we made use of a GFP-Pleckstrin Homology domain fusion protein
(GPH) expressed from the ubiquitously active β-Tubulin promoter (tGPH).
Insulin-signaling activity causes recruitment of the GPH protein to the plasma
membrane53. Hypoxia was induced at 72 h AEL, and hypoxic animals were assayed
for fat-body GFP localization 24 h later together with age-matched 96 h AEL
normoxic controls. Fat bodies were dissected in cold Schneider’s medium and
immediately imaged. To determine whether the fat body experiences biologically
relevant hypoxia under 5% ambient oxygen levels and whether Hph activity is
responsive to AA levels, we used a GFP::ODD sensor line, made up of the ODD
of Sima fused to GFP, expressed throughout the animal from the ubiquitin-69E
promoter54. Similar to endogenous Sima protein, the GFP::ODD reporter is
degraded at a rate reﬂecting Hph activity; thus, in normal conditions, the GFP
signal is low, whereas in hypoxia or other conditions of Hph inhibition, the GFP
signal is increased. Unmodiﬁed RFP expressed from the same regulatory elements
provides a ratiometric denominator. For hypoxia tests, larvae were reared under
normoxia or hypoxia until 96 or 120 h AEL, respectively, at which point fat bodies
were dissected in cold Schneider’s medium and immediately imaged. For protein-
starvation assays, animals were reared in normoxia at 25 °C on standard (1× yeast)
diets until 92 h AEL and then transferred either to a fresh vial of the same diet or to
protein-starvation medium (sugar alone) for 4 h; fat bodies were dissected in cold
Schneider’s medium (non-starved animals) or cold PBS (starved animals, to pre-
vent uptake of AAs). Confocal stacks of endogenous xFP ﬂuorescence were taken
immediately. Levels of GFP and RFP signals were integrated using the FIJI package,
and the ratio between them was calculated. LDs were imaged using label-free
Coherent Anti-Stokes Raman Scattering (CARS) microscopy. For normoxia assays,
animals were reared on standard diet in normoxia until harvest (for HphΔ9, at
120 h; otherwise, 96 h). For hypoxia assays, w1118 and simaKG07607 animals were
reared for 120 h in hypoxia; HphΔ9 animals died when reared in hypoxia, so these
animals were reared in normoxia for 120 h and then transferred to hypoxia for 16 h
before harvest. For measurements of response to AA starvation, w1118 and
simaKG07607 animals were reared on standard (1× yeast) for 96 h and HphΔ9 for
120 h, and then transferred to sugar-only diet for 16 h. Fat bodies were dissected in
cold Schneider’s culture medium and immediately imaged using a Leica TCS SP8
confocal microscope85,86, using a picoEmerald laser and BS635 ﬁlter for lipids
along with these settings: IR power, 2000 mW; OPO, 2000 mW at 780–940 nm,
pulse width 5–6 ps, 80MHz; pump, 1174 mW at 1064 nm, pulse length 7 ps,
80 MHz. To image lipids, the lasers were tuned to the C–H stretching vibration:
pump beam, 816.4 nm; Stokes beam, 1,064.6 nm; laser output, 1.3 W; scan speed,
400 Hz. Signals were collected from the epi-CARS and epi-SHG detectors. LD size
was quantiﬁed using the FIJI software package.
RNAi mini-screen of fat-body factors and IPC receptors. R96A08-GAL4, tar-
geting the IPCs, was crossed to RNAi constructs against receptors, and the fat-body
driver AkhR-GAL4::p65 was crossed to lines targeting secreted factors. Fat-body
driver ppl-GAL4 was crossed to daw-RNAi and UAS-Rheb. Newly hatched larvae
from 4 h egg lays were transferred at 24 h AEL to standard food vials and incubated
at 25 °C in normoxia or hypoxia (5% O2) until pupariation. Pupal size was mea-
sured, and for each genotype the ratio for each possible hypoxic and normoxic vial
pair was computed to make up each data set. Experimental data were compared
with data from controls expressing UAS-Luciferase in a background matching that
of the RNAi lines, except for the ΔGbp1,2 deletion line, which was normalized to
w1118, and ppl> crosses, which were compared with ppl-GAL4/+.
Statistical analyses. Statistical tests and P-values are given within each ﬁgure
legend. Statistics were calculated using GraphPad Prism Software, applying analysis
of variance, Dunnett’s test, or Kruskal–Wallis non-parametric tests for multiple-
comparisons tests and two-tailed Student’s t-tests or two-tailed exact
Mann–Whitney non-parametric tests for pairwise comparisons. Error bars indicate
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SEM and P-values are indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001, and
****P < 0.0001.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data that support the ﬁndings of the current study are available from the corresponding
author on reasonable request.
Received: 15 June 2018 Accepted: 10 April 2019
References
1. Danielsen, E. T., Moeller, M. E. & Rewitz, K. F. Nutrient signaling and
developmental timing of maturation. Curr. Top. Dev. Biol. 105, 37–67 (2013).
2. Tennessen, J. M. & Thummel, C. S. Coordinating growth and maturation -
insights from Drosophila. Curr. Biol. 21, R750–R757 (2011).
3. Callier, V. & Nijhout, H. F. Control of body size by oxygen supply reveals size-
dependent and size-independent mechanisms of molting and metamorphosis.
Proc. Natl Acad. Sci. USA 108, 14664–14669 (2011).
4. Callier, V. et al. The role of reduced oxygen in the developmental physiology
of growth and metamorphosis initiation in Drosophila melanogaster.
J. Exp. Biol. 216, 4334–4340 (2013).
5. Hietakangas, V. & Cohen, S. M. Regulation of tissue growth through nutrient
sensing. Annu Rev. Genet. 43, 389–410 (2009).
6. Boulan, L., Milan, M. & Leopold, P. The systemic control of growth. Cold
Spring Harb. Perspect. Biol. 7, pii: a019117 https://doi.org/10.1101/
cshperspect.a019117 (2015).
7. Ikeya, T., Galic, M., Belawat, P., Nairz, K. & Hafen, E. Nutrient-dependent
expression of insulin-like peptides from neuroendocrine cells in the CNS
contributes to growth regulation in Drosophila. Curr. Biol. 12, 1293–1300
(2002).
8. Wang, S., Tulina, N., Carlin, D. L. & Rulifson, E. J. The origin of islet-like cells
in Drosophila identiﬁes parallels to the vertebrate endocrine axis. Proc. Natl
Acad. Sci. USA 104, 19873–19878 (2007).
9. Rajan, A. & Perrimon, N. Drosophila cytokine unpaired 2 regulates
physiological homeostasis by remotely controlling insulin secretion. Cell 151,
123–137 (2012).
10. Sano, H. et al. The nutrient-responsive hormone CCHamide-2 controls
growth by regulating insulin-like peptides in the brain of Drosophila
melanogaster. PLoS Genet 11, e1005209 (2015).
11. Sun, J. et al. Drosophila FIT is a protein-speciﬁc satiety hormone essential for
feeding control. Nat. Commun. 8, 14161 (2017).
12. Koyama, T. & Mirth, C. K. Growth-blocking peptides as nutrition-sensitive
signals for insulin secretion and body size regulation. PLoS Biol. 14, e1002392
(2016).
13. Meschi, E., Leopold, P. & Delanoue, R. An EGF-responsive neural circuit
couples insulin secretion with nutrition in Drosophila. Dev. Cell 48, 76–86 e75
(2019).
14. Ghosh, A. C. & O’Connor, M. B. Systemic Activin signaling independently
regulates sugar homeostasis, cellular metabolism, and pH balance in
Drosophila melanogaster. Proc. Natl Acad. Sci. USA 111, 5729–5734 (2014).
15. Bai, H., Kang, P., Hernandez, A. M. & Tatar, M. Activin signaling targeted by
insulin/dFOXO regulates aging and muscle proteostasis in Drosophila. PLoS
Genet. 9, e1003941 (2013).
16. Delanoue, R. et al. Drosophila insulin release is triggered by adipose Stunted
ligand to brain Methuselah receptor. Science 353, 1553–1556 (2016).
17. Agrawal, N. et al. The Drosophila TNF Eiger is an adipokine that acts on
insulin-producing cells to mediate nutrient response. Cell Metab. 23, 675–684
(2016).
18. Palos, L. A. & Blasko, G. Effect of hypoxia on the development of Drosophila
melanogaster (Meigen). Aviat. Space Environ. Med. 50, 411–412 (1979).
19. Callier, V. & Nijhout, H. F. Body size determination in insects: a review and
synthesis of size- and brain-dependent and independent mechanisms. Biol.
Rev. Camb. Philos. Soc. 88, 944–954 (2013).
20. Henry, J. R. & Harrison, J. F. Plastic and evolved responses of larval tracheae
and mass to varying atmospheric oxygen content in Drosophila melanogaster.
J. Exp. Biol. 207, 3559–3567 (2004).
21. Peck, L. S. & Maddrell, S. H. P. Limitation of size by hypoxia in the fruit ﬂy
Drosophila melanogaster. J. Exp. Zool. A Comp. Exp. Biol. 303A, 968–975
(2005).
22. Frazier, M. R., Woods, H. A. & Harrison, J. F. Interactive effects of rearing
temperature and oxygen on the development of Drosophila melanogaster.
Physiol. Biochem. Zool. 74, 641–650 (2001).
23. Frisancho, A. R. Developmental functional adaptation to high altitude: review.
Am. J. Hum. Biol. 25, 151–168 (2013).
24. Frisancho, A. R. & Baker, P. T. Altitude and growth: a study of the patterns
of physical growth of a high altitude Peruvian Quechua population. Am. J.
Phys. Anthr. 32, 279–292 (1970).
25. Van Voorhies, W. A. Metabolic function in Drosophila melanogaster in
response to hypoxia and pure oxygen. J. Exp. Biol. 212, 3132–3141 (2009).
26. Harrison, J. F., Shingleton, A. W. & Callier, V. Stunted by developing in
hypoxia: linking comparative and model organism studies. Physiol. Biochem
Zool. 88, 455–470 (2015).
27. Gorr, T. A., Gassmann, M. & Wappner, P. Sensing and responding to hypoxia
via HIF in model invertebrates. J. Insect Physiol. 52, 349–364 (2006).
28. Klambt, C., Glazer, L. & Shilo, B. Z. breathless, a Drosophila FGF receptor
homolog, is essential for migration of tracheal and speciﬁc midline glial cells.
Genes Dev. 6, 1668–1678 (1992).
29. Jarecki, J., Johnson, E. & Krasnow, M. A. Oxygen regulation of airway
branching in Drosophila is mediated by branchless FGF. Cell 99, 211–220
(1999).
30. Sutherland, D., Samakovlis, C. & Krasnow, M. A. branchless encodes a
Drosophila FGF homolog that controls tracheal cell migration and the pattern
of branching. Cell 87, 1091–1101 (1996).
31. Dietzl, G. et al. A genome-wide transgenic RNAi library for conditional gene
inactivation in Drosophila. Nature 448, 151–156 (2007).
32. Ni, J. Q. et al. A genome-scale shRNA resource for transgenic RNAi in
Drosophila. Nat. Methods 8, 405–407 (2011).
33. Chen, C., Jack, J. & Garofalo, R. S. The Drosophila insulin receptor is required
for normal growth. Endocrinology 137, 846–856 (1996).
34. Loren, C. E. et al. Identiﬁcation and characterization of DAlk: a novel
Drosophila melanogaster RTK which drives ERK activation in vivo. Genes Cells
6, 531–544 (2001).
35. Okamoto, N. & Nishimura, T. Signaling from glia and cholinergic neurons
controls nutrient-dependent production of an insulin-like peptide for
Drosophila body growth. Dev. Cell 35, 295–310 (2015).
36. Diaz-Benjumea, F. J. & Garcia-Bellido, A. Behaviour of cells mutant for an
EGF receptor homologue of Drosophila in genetic mosaics. Proc. Biol. Sci. 242,
36–44 (1990).
37. Rewitz, K. F., Yamanaka, N., Gilbert, L. I. & O’Connor, M. B. The insect
neuropeptide PTTH activates receptor tyrosine kinase torso to initiate
metamorphosis. Science 326, 1403–1405 (2009).
38. Danielsen, E. T. et al. Transcriptional control of steroid biosynthesis genes in
the Drosophila prothoracic gland by ventral veins lacking and knirps. PLoS
Genet. 10, e1004343 (2014).
39. Bialecki, M., Shilton, A., Fichtenberg, C., Segraves, W. A. & Thummel, C. S.
Loss of the ecdysteroid-inducible E75A orphan nuclear receptor uncouples
molting from metamorphosis in Drosophila. Dev. Cell 3, 209–220 (2002).
40. Huang, X., Warren, J. T., Buchanan, J., Gilbert, L. I. & Scott, M. P. Drosophila
Niemann-Pick type C-2 genes control sterol homeostasis and steroid
biosynthesis: a model of human neurodegenerative disease. Development 134,
3733–3742 (2007).
41. Wilk, R., Weizman, I. & Shilo, B. Z. trachealess encodes a bHLH-PAS protein
that is an inducer of tracheal cell fates in Drosophila. Genes Dev. 10, 93–102
(1996).
42. Ohshiro, T., Emori, Y. & Saigo, K. Ligand-dependent activation of breathless
FGF receptor gene in Drosophila developing trachea. Mech. Dev. 114, 3–11
(2002).
43. Glazer, L. & Shilo, B. Z. The Drosophila FGF-R homolog is expressed in the
embryonic tracheal system and appears to be required for directed tracheal
cell extension. Genes Dev. 5, 697–705 (1991).
44. Kim, J. & Neufeld, T. P. Dietary sugar promotes systemic TOR activation
in Drosophila through AKH-dependent selective secretion of Dilp3. Nat.
Commun. 6, 6846 (2015).
45. Puig, O. & Tjian, R. Transcriptional feedback control of insulin receptor by
dFOXO/FOXO1. Genes Dev. 19, 2435–2446 (2005).
46. Colombani, J. et al. Antagonistic actions of ecdysone and insulins determine
ﬁnal size in Drosophila. Science 310, 667–670 (2005).
47. Jones, T. A. & Metzstein, M. M. Examination of Drosophila larval tracheal
terminal cells by light microscopy. J. Vis. Exp., e50496, https://doi.org/
10.3791/50496 (2013).
48. Nambu, J. R., Chen, W., Hu, S. & Crews, S. T. The Drosophila melanogaster
similar bHLH-PAS gene encodes a protein related to human hypoxia-
inducible factor 1 alpha and Drosophila single-minded. Gene 172, 249–254
(1996).
49. Frei, C. & Edgar, B. A. Drosophila cyclin D/Cdk4 requires Hif-1 prolyl
hydroxylase to drive cell growth. Dev. Cell 6, 241–251 (2004).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09943-y ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1955 | https://doi.org/10.1038/s41467-019-09943-y | www.nature.com/naturecommunications 15
50. Bruick, R. K. & McKnight, S. L. A conserved family of prolyl-4-hydroxylases
that modify HIF. Science 294, 1337–1340 (2001).
51. Park, S. et al. A genetic strategy to measure circulating Drosophila insulin
reveals genes regulating insulin production and secretion. PLoS Genet. 10,
e1004555 (2014).
52. Geminard, C., Rulifson, E. J. & Leopold, P. Remote control of insulin secretion
by fat cells in Drosophila. Cell Metab. 10, 199–207 (2009).
53. Britton, J. S., Lockwood, W. K., Li, L., Cohen, S. M. & Edgar, B. A. Drosophila’s
insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional
conditions. Dev. Cell 2, 239–249 (2002).
54. Misra, T. et al. A genetically encoded biosensor for visualising hypoxia
responses in vivo. Biol. Open 6, 296–304 (2017).
55. Colombani, J. et al. A nutrient sensor mechanism controls Drosophila growth.
Cell 114, 739–749 (2003).
56. Centanin, L., Ratcliffe, P. J. & Wappner, P. Reversion of lethality and growth
defects in Fatiga oxygen-sensor mutant ﬂies by loss of hypoxia-inducible
factor-alpha/Sima. EMBO Rep. 6, 1070–1075 (2005).
57. Romero-Pozuelo, J., Demetriades, C., Schroeder, P. & Teleman, A. A. CycD/
Cdk4 and discontinuities in Dpp signaling activate TORC1 in the Drosophila
wing disc. Dev. Cell 42, 376–387 e375 (2017).
58. Reiling, J. H. & Hafen, E. The hypoxia-induced paralogs Scylla and Charybdis
inhibit growth by down-regulating S6K activity upstream of TSC in
Drosophila. Genes Dev. 18, 2879–2892 (2004).
59. Brugarolas, J. et al. Regulation of mTOR function in response to hypoxia by
REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18,
2893–2904 (2004).
60. Gronke, S., Clarke, D. F., Broughton, S., Andrews, T. D. & Partridge, L.
Molecular evolution and functional characterization of Drosophila insulin-like
peptides. PLoS Genet 6, e1000857 (2010).
61. Xu, G. G. & Rothenberg, P. L. Insulin receptor signaling in the beta-cell
inﬂuences insulin gene expression and insulin content: evidence for autocrine
beta-cell regulation. Diabetes 47, 1243–1252 (1998).
62. Cantley, J. The control of insulin secretion by adipokines: current evidence for
adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm.
Genome 25, 442–454 (2014).
63. Wu, L. E. et al. Identiﬁcation of fatty acid binding protein 4 as an
adipokine that regulates insulin secretion during obesity. Mol. Metab. 3,
465–473 (2014).
64. Krock, B. L., Skuli, N. & Simon, M. C. Hypoxia-induced angiogenesis: good
and evil. Genes Cancer 2, 1117–1133 (2011).
65. Fong, G. H. Mechanisms of adaptive angiogenesis to tissue hypoxia.
Angiogenesis 11, 121–140 (2008).
66. Regazzetti, C. et al. Hypoxia decreases insulin signaling pathways in
adipocytes. Diabetes 58, 95–103 (2009).
67. Pasarica, M. et al. Reduced adipose tissue oxygenation in human obesity:
evidence for rarefaction, macrophage chemotaxis, and inﬂammation without
an angiogenic response. Diabetes 58, 718–725 (2009).
68. Polotsky, V. Y. et al. Intermittent hypoxia increases insulin resistance in
genetically obese mice. J. Physiol. 552, 253–264 (2003).
69. Norouzirad, R., Gonzalez-Muniesa, P. & Ghasemi, A. Hypoxia in obesity and
diabetes: potential therapeutic effects of hyperoxia and nitrate. Oxid. Med Cell
Longev. 2017, 5350267 (2017).
70. Rasouli, N. Adipose tissue hypoxia and insulin resistance. J. Invest. Med 64,
830–832 (2016).
71. Hosogai, N. et al. Adipose tissue hypoxia in obesity and its impact on
adipocytokine dysregulation. Diabetes 56, 901–911 (2007).
72. Lefere, S. et al. Hypoxia-regulated mechanisms in the pathogenesis of
obesity and non-alcoholic fatty liver disease. Cell Mol. Life Sci. 73, 3419–3431
(2016).
73. Kihira, Y. et al. Deletion of hypoxia-inducible factor-1alpha in adipocytes
enhances glucagon-like peptide-1 secretion and reduces adipose tissue
inﬂammation. PLoS ONE 9, e93856 (2014).
74. Ryan, S. Adipose tissue inﬂammation by intermittent hypoxia: mechanistic
link between obstructive sleep apnoea and metabolic dysfunction. J. Physiol.
595, 2423–2430 (2017).
75. Masson, N. & Ratcliffe, P. J. Hypoxia signaling pathways in cancer
metabolism: the importance of co-selecting interconnected physiological
pathways. Cancer Metab. 2, 3 (2014).
76. Pfeiffer, B. D. et al. Reﬁnement of tools for targeted gene expression in
Drosophila. Genetics 186, 735–755 (2010).
77. Venken, K. J. et al. Versatile P[acman] BAC libraries for transgenesis studies
in Drosophila melanogaster. Nat. Methods 6, 431–434 (2009).
78. Pfeiffer, B. D. et al. Tools for neuroanatomy and neurogenetics in Drosophila.
Proc. Natl Acad. Sci. USA 105, 9715–9720 (2008).
79. Honegger, B. et al. Imp-L2, a putative homolog of vertebrate IGF-binding
protein 7, counteracts insulin signaling in Drosophila and is essential for
starvation resistance. J. Biol. 7, 10 (2008).
80. Stocker, H. et al. Rheb is an essential regulator of S6K in controlling cell
growth in Drosophila. Nat. Cell Biol. 5, 559–565 (2003).
81. Moeller, M. E. et al. Warts signaling controls organ and body growth through
regulation of ecdysone. Curr. Biol. 27, 1652–1659 e1654 (2017).
82. Port, F. & Bullock, S. L. Augmenting CRISPR applications in Drosophila with
tRNA-ﬂanked sgRNAs. Nat. Methods 13, 852–854 (2016).
83. Huynh, N., Zeng, J., Liu, W. & King-Jones, K. A Drosophila CRISPR/Cas9
toolkit for conditionally manipulating gene expression in the prothoracic
gland as a test case for polytene tissues. G3 8, 3593–3605 (2018).
84. Soderberg, J. A., Birse, R. T. & Nassel, D. R. Insulin production and signaling
in renal tubules of Drosophila is under control of tachykinin-related peptide
and regulates stress resistance. PLoS ONE 6, e19866 (2011).
85. Danielsen, E. T. et al. A Drosophila genome-wide screen identiﬁes regulators
of steroid hormone production and developmental timing. Dev. Cell 37,
558–570 (2016).
86. Hentze, J. L., Carlsson, M. A., Kondo, S., Nassel, D. R. & Rewitz, K. F. The
neuropeptide allatostatin A regulates metabolism and feeding decisions in
Drosophila. Sci. Rep. 5, 11680 (2015).
Acknowledgements
We thank our Erasmus-program visiting undergraduate Niyati Jain for help. We are
grateful to Seung Kim, Pierre Léopold, Stefan Luschnig, Dick Nässel, Sangbin Park,
Aurelio Teleman, Jan Veenstra, and Pablo Wappner for kindly sharing antibodies, ﬂy
lines, and reagents. We also thank Addgene, the Bloomington Drosophila Stock Center,
and the Vienna Drosophila Resource Center for making plasmids and ﬂy lines broadly
available. This work was supported by the Novo Nordisk Foundation STAR grant and an
Innovation foundation grant to J.L.H. and K.F.R. and by Novo Nordisk Foundation grant
16OC0021270 and Danish Council for Independent Research Natural Sciences grant
4181-00270 to K.F.R. K.A.H. was supported by Villum Foundation grant 15365 to K.A.H.
Author contributions
M.J.T., A.F.J., C.F.C., T.K., A.M., D.K.S., D.F.M.M., E.T.D., S.K.P., K.A.H. and K.F.R.
performed the experiments and analyzed the data. M.J.T., A.F.J., C.F.C., J.L.H., K.A.H.
and K.F.R. designed the experiments. M.J.T., K.A.H. and K.F.R. wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-09943-y.
Competing interests: J.L.H. is an employee and shareholder of Novo Nordisk A/S. A.F.J.
is an employee of Novo Nordisk A/S. All remaining authors declare no competing
interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Journal peer review information: Nature Communications thanks Dan Zhou and other
anonymous reviewer(s) for their contribution to the peer review of this work. Peer
reviewer reports are available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09943-y
16 NATURE COMMUNICATIONS |         (2019) 10:1955 | https://doi.org/10.1038/s41467-019-09943-y | www.nature.com/naturecommunications
